Skip to content

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05450523
Enrollment
220
Registered
2022-07-08
Start date
2021-12-28
Completion date
2022-09-07
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritoneal Dialysis-associated Peritonitis

Brief summary

According to the requirements of the Technical Guidelines for Clinical Trials of In Vitro Diagnostic Reagents, the first registered product (hereinafter referred to as the assessment reagent) - Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) was tested in clinical institutions. ) for clinical validation trials. Prove that the clinical performance of the assessment reagent meets the requirements of the intended use.

Interventions

None listed

Sponsors

Qingdao HIGHTOP Biotech Co., Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patients treated with peritoneal dialysis due to kidney disease, including those with confirmed peritonitis and those without peritonitis. There are no age or gender requirements, and informed consent is required.

Exclusion criteria

1. Patients who have been treated with antibiotics for peritonitis before taking the sample. 2. Incomplete information, including: sample ID number, gender, age, department, clinical diagnosis, sample type, and sampling date. 3. The sample size is insufficient. 4. Repeated cases. 5. The samples whose permeate is red in visual inspection.

Design outcomes

Primary

MeasureTime frameDescription
Assessment reagent test results and clinical reference standard statistics8 monthsThe peritoneal dialysis effluent collected from the subjects was tested blindly with the assessment reagents, and the test results were compared with the clinical reference standards. By evaluating the clinical sensitivity and specificity of the assessment reagents, the feasibility of clinical application of the assessment reagents was evaluated.
Statistical analysis of non-professional self-testing test8 monthsThere is no need to train non-professionals. After reading the instructions and labels, non-professionals can evaluate their ability to understand key information such as instructions and packaging labels through questionnaires; Research, comparison of test results of different forms of reagents, and comparison with professional test results to evaluate their operational capabilities.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026